Lejian Biotech PeptideRetatrutide
Ordered Retatrutide from Lejian Biotech Peptide? Mail in a sample (US only) and let us test it for free.
Test my supplyBatch documentation is uneven for Lejian Biotech Peptide Retatrutide, the main caveat to otherwise low-concern purity-focus evidence: identity passed, purity held 99.5–99.95%, and one fill ran +17%.
The investigation follows an offline registrar-held domain, a Hong Kong legal name with unresolved filings, and sales pushed into forum, Telegram, WhatsApp, and Discord. It maps warehouse expansion, private COA trails, regulatory disruption, and persistent impersonation warnings.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Lejian Biotech Peptide rows.
Cancel anytime
About Lejian Biotech Peptide test results from Finnrick
Lejian Biotech Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 8 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Lejian Biotech Peptide peptides in this dataset are Retatrutide (8 tests), Tesamorelin (0 tests) and Tirzepatide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 8 recent tests.
Ordered Retatrutide from Lejian Biotech Peptide? Mail in a sample (US only) and let us test it for free.
Test my supply